To Investigate the Pharmacokinetics and Safety of Fluticasone Furoate (FF)/ Umeclidinium (UMEC) Combination Compared With FF and UMEC Monotherapies in Adult Healthy Volunteers Using a Dry Powder Inhaler (DPI)
Clinical trial NCT01725685 · COMPLETED
Trial details
- NCT number
- NCT01725685
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-08
- Primary completion
- 2013-01-02
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.